Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Adtalem Global Education Inc. (NYSE: ATGE), a for-profit operator of colleges, universities, and professional schools with a strong emphasis on healthcare education. As a New York Stock Exchange–listed company, Adtalem files periodic and current reports that offer detailed information on its operations, financial condition, governance, and shareholder-related actions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain segment-level data for the Chamberlain, Walden, and Medical and Veterinary segments, along with discussions of enrollment, revenue, operating income, and risk factors. These filings help readers understand how institutions such as Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine contribute to Adtalem’s overall results.
Current reports on Form 8-K document specific material events. Recent 8-K filings have covered the announcement of a new share repurchase authorization of up to $750 million and the completion of a prior $150 million repurchase program, the release of quarterly financial results, the retirement of the president of Chamberlain University, and the adoption of a Rule 10b5-1 trading plan by the company’s chief executive officer. Another 8-K reports the results of Adtalem’s annual meeting of shareholders, including director elections, auditor ratification, and an advisory vote on executive compensation.
Investors can also review Forms 4 and related insider trading disclosures referenced in company communications, which report transactions executed under trading plans such as the disclosed Rule 10b5-1 plan. Together, these filings provide a regulatory record of Adtalem’s financial performance, capital allocation decisions, governance matters, and insider activity.
Stock Titan’s platform enhances these filings with AI-powered summaries that highlight key points from lengthy documents, making it easier to identify segment performance, capital allocation actions, and governance changes without reading every page. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 filings for ATGE are available promptly, while AI-generated explanations help readers interpret complex disclosures in accessible language.
Adtalem Global Education (ATGE) reported a Form 4 for its VP, Chief Accounting Officer. On 11/12/2025, the officer acquired 890 shares of common stock at a reported price of $96.86, noted as restricted stock units that convert one-for-one. On 11/13/2025, 94 shares were withheld at $96.26 to cover taxes upon vesting of prior RSUs.
The RSUs vest in three equal installments beginning on November 12, 2026. Following the transactions, directly owned shares were 5,697. This filing reflects routine equity compensation activity and associated tax withholding by a company officer.
Adtalem Global Education (ATGE) reported insider equity activity. An officer acquired 2,075 restricted stock units on 11/12/2025 at $96.86 per the filing notes. These RSUs convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026.
On 11/13/2025, 361 shares were withheld at $96.26 to satisfy tax obligations upon the vesting of previously awarded RSUs. Following these transactions, the officer directly owned 47,774 shares of common stock.
Adtalem Global Education (ATGE) reported insider activity by an officer (President, Chamberlain University). On 11/12/2025, the officer reported an acquisition of 581 restricted stock units at $96.86 per share equivalent. The RSUs convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026. On 11/13/2025, 310 shares were withheld at $96.26 to satisfy taxes upon the vesting of a prior RSU award. Following these transactions, the officer directly holds 33,596 shares.
Adtalem Global Education (ATGE) director reported equity transactions on Form 4. On 11/12/2025, the director received 1,445 restricted stock units as director compensation, calculated using the $96.86 ATGE closing price. These stock units vest 100% one year after the grant date.
On 11/13/2025, 390 shares were withheld to satisfy tax obligations upon vesting of prior RSUs at a reference price of $96.26. Following these transactions, the director directly beneficially owned 10,423 shares.
Adtalem Global Education (ATGE) reported an insider equity award and related tax withholding. On 11/12/2025, an officer (Pres. Walden University & CDO) acquired 5,575 restricted stock units (RSUs) of common stock (Code A) at a reported price of $96.86, raising beneficial ownership to 33,727 shares/direct. On 11/13/2025, 441 shares were withheld/disposed (Code F) at $96.26 to satisfy taxes upon vesting of prior RSUs, leaving 33,286 shares/direct.
The filing notes these RSUs convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026. This reflects routine equity compensation and tax settlement activity.
Adtalem Global Education (ATGE) reported a routine insider transaction on a Form 4. The Chairman & CEO executed a Code F transaction, withholding 9,204 shares of common stock at $96.26 to satisfy taxes upon the vesting of previously awarded RSUs on 11/13/2025.
Following this tax withholding, the officer now beneficially owns 450,530 shares, held directly. The filing notes the activity was tied to RSU vesting and reflects non-open-market share withholding to cover tax obligations.
Adtalem Global Education (ATGE) reported an insider transaction by its Chief Financial Officer. On 11/10/2025, the CFO had 1,637 shares of common stock withheld to satisfy tax obligations upon the vesting of previously awarded restricted stock units, coded F, at a price of $95.19 per share.
Following this tax withholding, the officer beneficially owns 62,170 shares of Adtalem common stock, held directly. The filing notes the shares were withheld specifically to cover taxes related to RSU vesting.
Adtalem Global Education (ATGE) reported a routine insider trade by a director. On November 5, 2025, the director purchased 508 shares of common stock at a price of $98.29 per share. Following the transaction, the director directly owned 18,783 shares. The filing was made by a single reporting person.
Adtalem Global Education (ATGE) reported an insider purchase. The company’s Lead Independent Director, a member of the board, purchased 1,000 shares of common stock at $91.85 on 11/04/2025. Following this transaction, the insider beneficially owns 100,445 shares, held directly.
Adtalem Global Education (ATGE) reported first-quarter fiscal 2026 results for the period ended September 30, 2025. Revenue rose to $462.3 million from $417.4 million, driven by Chamberlain $179.2 million, Walden $190.0 million, and Medical & Veterinary $93.1 million. Operating income increased to $85.5 million and net income to $61.8 million, with diluted EPS of $1.67 versus $1.18 a year ago.
Cash from operations was strong at $130.6 million, lifting cash and equivalents to $264.7 million. Interest expense declined to $11.1 million. The company repurchased 56,817 shares for $7.6 million in the quarter; $142.4 million remains authorized. Deferred revenue rose to $322.9 million, reflecting student billing cycles and material rights.
Adtalem ended the quarter with long-term debt principal of $558.3 million (Notes $405.0 million, Term Loan B $153.3 million) and subsequently prepaid $50.0 million on
FAQ
What is the current stock price of Adtalem Global Ed (ATGE)?
What is the market cap of Adtalem Global Ed (ATGE)?
